{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:26:05Z","timestamp":1788402365605,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014569","name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.msard.2024.105501","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:40:08Z","timestamp":1707784808000},"page":"105501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"84","author":[{"given":"Miguel","family":"Llaneza Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Carrascal Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Delgado S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Borges Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Rodr\u00edguez Antig\u00fcedad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Morell Baladr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Becerril R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0lex","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgina","family":"Meca Lallana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-4196","authenticated-orcid":false,"given":"Laura","family":"Benedito-Palos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Comellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainara","family":"Echeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-5716","authenticated-orcid":false,"given":"Celia","family":"Oreja-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105501_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41687-018-0062-5","article-title":"The feasibility of implementing the ICHOM standard set for hip and knee osteoarthritis: a mixed-methods evaluation in public and private hospital settings","volume":"2","author":"Ackerman","year":"2017","journal-title":"J. Patient. Rep. Outcomes."},{"key":"10.1016\/j.msard.2024.105501_bib0002","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0003","article-title":"Patient-reported outcome measures in MS: do development processes and patient involvement support valid quantification of clinically important variables?","volume":"8","author":"Bharadia","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2024.105501_bib0004","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105501_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103464","article-title":"I'm walking into the unknown\": qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatment","volume":"58","author":"Carey","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105501_bib0006","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(16)32388-1","article-title":"Evolving concepts in the treatment of relapsing multiple sclerosis","volume":"389","author":"Comi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2024.105501_bib0007","unstructured":"EuroQol Group. EQ-5D-5L, https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/(accessed 07\/12\/ 2022)."},{"key":"10.1016\/j.msard.2024.105501_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2377-11-127","article-title":"Validation of the Spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire","volume":"11","author":"Fern\u00e1ndez","year":"2011","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2024.105501_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"The impact of fatigue on patients with multiple sclerosis","volume":"21","author":"Fisk","year":"1994","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105501_bib0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/fampra\/10.1.76","article-title":"The nominal group technique: a research tool for general practice?","volume":"10","author":"Gallagher","year":"1993","journal-title":"Fam. Pract."},{"key":"10.1016\/j.msard.2024.105501_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041249","article-title":"Quality of life in adults with multiple sclerosis: a systematic review","volume":"10","author":"Gil-Gonz\u00e1lez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.msard.2024.105501_bib0012","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1016\/j.msard.2024.105501_bib0013","unstructured":"International Consortium for Health Outcomes Measurement (ICHOM), https:\/\/www.ichom.org\/standard-sets\/(accessed 26\/10\/ 2021)."},{"key":"10.1016\/j.msard.2024.105501_bib0014","article-title":"Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: a 10-year follow-up study","volume":"7","author":"Jacobsen","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2024.105501_bib0015","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/1352458518803785","article-title":"Recommendations for cognitive screening and management in multiple sclerosis care","volume":"24","author":"Kalb","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1191\/1352458505ms1117oa","article-title":"Evaluation of the Modified Fatigue Impact Scale in four different European countries","volume":"11","author":"Kos","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0017","doi-asserted-by":"crossref","first-page":"709","DOI":"10.17219\/acem\/62329","article-title":"Rehabilitation in multiple sclerosis","volume":"26","author":"Kubsik-Gidlewska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.msard.2024.105501_bib0018","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105501_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182413245","article-title":"Exercise training for multiple sclerosis: a narrative review of history, benefits, safety, guidelines, and promotion","volume":"18","author":"Learmonth","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.msard.2024.105501_bib0020","first-page":"1653","article-title":"Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature","volume":"8","author":"Liz\u00e1n","year":"2014","journal-title":"Patient. Prefer. Adher."},{"key":"10.1016\/j.msard.2024.105501_bib0021","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105501_bib0022","first-page":"1273","article-title":"Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression","volume":"27","author":"Mardan","year":"2021","journal-title":"J. Manage Care Spec. Pharm."},{"key":"10.1016\/j.msard.2024.105501_bib0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2377-14-58","article-title":"Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis","volume":"14","author":"Meyer-Moock","year":"2014","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2024.105501_bib0024","series-title":"Applied Social Research Methods Series. Group Techniques For Idea Building","author":"Moore","year":"1987"},{"key":"10.1016\/j.msard.2024.105501_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-981-15-1792-1_22","article-title":"Exercise and multiple sclerosis","volume":"1228","author":"Motl","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.msard.2024.105501_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1191\/1352458503ms871oa","article-title":"The use of quality of life measures in multiple sclerosis research","volume":"9","author":"Nortvedt","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0027","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s13311-017-0571-6","article-title":"Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials","volume":"14","author":"Nowinski","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.msard.2024.105501_bib0028","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000117270","article-title":"Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts","volume":"36","author":"Pasquier","year":"1996","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2024.105501_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0025-7753(15)30002-6","article-title":"Descripci\u00f3n actual de la esclerosis m\u00faltiple","volume":"143","author":"R\u00edo","year":"2014","journal-title":"Medicina Cl\u00ednica"},{"key":"10.1016\/j.msard.2024.105501_bib0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00023210-200822100-00004","article-title":"Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment","volume":"22","author":"Rudick","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2024.105501_bib0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458507080733","article-title":"Validation of the multiple sclerosis international quality of life questionnaire","volume":"14","author":"Simeoni","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7525-3-16","article-title":"Role of health-related quality of life measures in the routine care of people with multiple sclerosis","volume":"3","author":"Solari","year":"2005","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.msard.2024.105501_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11940-016-0411-8","article-title":"Fatigue management in multiple sclerosis","volume":"18","author":"Tur","year":"2016","journal-title":"Curr. Treat. Options. Neurol."},{"key":"10.1016\/j.msard.2024.105501_bib0034","doi-asserted-by":"crossref","first-page":"517","DOI":"10.12688\/f1000research.6378.1","article-title":"Novel insights and therapeutics in multiple sclerosis","volume":"4","author":"Wagner","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.msard.2024.105501_bib0035","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105501_bib0036","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:08:39Z","timestamp":1761901719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"alternative-id":["S2211034824000804"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105501","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105501"}}